What is Acor Orthopaedic?
Acor Home specializes in the creation of custom orthotic solutions, including a comprehensive range of ankle-foot orthoses (AFOs) and braces engineered to enhance patient mobility and provide essential support. The company utilizes advanced materials such as EVA, polyurethane, and neoprene to ensure the durability and comfort of its orthopedic devices. Acor Home's primary market includes healthcare professionals and individuals requiring personalized orthotic interventions, reflecting a commitment to improving the quality of life for those facing mobility challenges through innovation and high-quality product development.
How much funding has Acor Orthopaedic raised?
Acor Orthopaedic has raised a total of $859K across 2 funding rounds:
Debt
$350K
Debt
$509K
Debt (2020): $350K with participation from PPP
Debt (2021): $509K led by PPP
Key Investors in Acor Orthopaedic
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Acor Orthopaedic?
The substantial enterprise-level funding and recent strategic investment indicate Acor Orthopaedic is poised for significant scaling and market expansion. This capital infusion is likely to fuel advancements in product research and development, potentially leading to new orthotic technologies or expanded product lines. Furthermore, the company may leverage this financial backing to enhance its manufacturing capabilities, broaden its distribution network, and strengthen its partnerships within the healthcare sector, solidifying its position as a leader in custom orthotics.
See full Acor Orthopaedic company page
